Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
90.12
-1.34 (-1.47%)
Mar 6, 2026, 9:41 AM EST - Market open
Rhythm Pharmaceuticals Employees
Rhythm Pharmaceuticals had 414 employees as of December 31, 2025. The number of employees increased by 131 or 46.29% compared to the previous year.
Employees
414
Change (1Y)
131
Growth (1Y)
46.29%
Revenue / Employee
$458,350
Profits / Employee
-$487,722
Market Cap
6.15B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,769 |
| CRISPR Therapeutics AG | 393 |
| Mirum Pharmaceuticals | 372 |
| Immunovant | 362 |
| Cogent Biosciences | 258 |
| Kymera Therapeutics | 238 |
| Arcellx | 209 |
| Protagonist Therapeutics | 132 |
RYTM News
- 4 days ago - Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity - GlobeNewsWire
- 7 days ago - Rhythm Pharmaceuticals, Inc. (RYTM) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update - GlobeNewsWire
- 14 days ago - Rhythm Pharmaceuticals Is Well-Positioned, Analyst Says Could Capture Big Share Of Rare Obesity Market - Benzinga
- 17 days ago - Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit - GlobeNewsWire
- 2 months ago - Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones - GlobeNewsWire
- 3 months ago - Rhythm: PWS Signal, HO Speed Bump, And The Case For A Rare-Obesity Blockbuster - Seeking Alpha